Ascierto PA - Search Results

1

Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma.

Palmieri G, Satriano SM, Budroni M, Cossu A, Tanda F, Canzanella S, Caracò C, Simeone E, Daponte A, Mozzillo N, Comella G, Castello G, Ascierto PA. Palmieri G, et al. Among authors: ascierto pa. BMC Cancer. 2006 Nov 15;6:266. doi: 10.1186/1471-2407-6-266. BMC Cancer. 2006. PMID: 17107608 Free PMC article.

2

The soluble interleukin-2 receptor as an indicator of clinical evolution in patients with ulcerative colitis.

Balzano A, Bove A, Leonardi E, Bevilacqua N, Grande G, Ascierto PA, Castello G. Balzano A, et al. Among authors: ascierto pa. Eur J Gastroenterol Hepatol. 1997 Feb;9(2):173-7. doi: 10.1097/00042737-199702000-00012. Eur J Gastroenterol Hepatol. 1997. PMID: 9058629

3

Immunological phenotype analysis of patients with Fanconi's anaemia and their family members.

Castello G, Gallo C, Napolitano M, Ascierto PA. Castello G, et al. Among authors: ascierto pa. Acta Haematol. 1998;100(1):39-43. doi: 10.1159/000040861. Acta Haematol. 1998. PMID: 9691145

4

Epiluminescence microscopy as a useful approach in the early diagnosis of cutaneous malignant melanoma.

Ascierto PA, Satriano RA, Palmieri G, Parasole R, Bosco L, Castello G. Ascierto PA, et al. Melanoma Res. 1998 Dec;8(6):529-37. doi: 10.1097/00008390-199812000-00008. Melanoma Res. 1998. PMID: 9918415

5

Adjuvant therapy of cutaneous melanoma.

Ascierto PA, Palmieri G. Ascierto PA, et al. Lancet. 1999 Jan 23;353(9149):328. doi: 10.1016/s0140-6736(05)74894-7. Lancet. 1999. PMID: 9929057 No abstract available.

6

3-year treatment with recombinant interferon-alpha as adjuvant therapy of cutaneous malignant melanoma.

Ascierto PA, Palmieri G, Parasole R, Daponte A, Castello G. Ascierto PA, et al. Int J Mol Med. 1999 Mar;3(3):303-6. doi: 10.3892/ijmm.3.3.303. Int J Mol Med. 1999. PMID: 10028056 Clinical Trial.

7

Polymerase chain reaction-based detection of circulating melanoma cells as an effective marker of tumor progression. Melanoma Cooperative Group.

Palmieri G, Strazzullo M, Ascierto PA, Satriano SM, Daponte A, Castello G. Palmieri G, et al. Among authors: ascierto pa. J Clin Oncol. 1999 Jan;17(1):304-11. doi: 10.1200/JCO.1999.17.1.304. J Clin Oncol. 1999. PMID: 10458247

8

Adjuvant treatment of melanoma using placebo or no therapies as control-arm: is it ethically correct?

Ascierto PA, Daponte A, Giuseppe P. Ascierto PA, et al. Melanoma Res. 1999 Oct;9(5):528-9. Melanoma Res. 1999. PMID: 10596921 No abstract available.

9

Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions. The Melanoma Cooperative Study.

Ascierto PA, Palmieri G, Celentano E, Parasole R, Caracò C, Daponte A, Chiofalo MG, Melucci MT, Mozzillo N, Satriano RA, Castello G. Ascierto PA, et al. Br J Dermatol. 2000 May;142(5):893-8. doi: 10.1046/j.1365-2133.2000.03468.x. Br J Dermatol. 2000. PMID: 10809845

10

Low doses interferon-alpha in the treatment of high-risk cutaneous melanoma. Melanoma Cooperative Group.

Ascierto PA, Palmieri G, Strazzullo M, Daponte A, Botti G, Satriano SM, Motti ML, Mozzillo N. Ascierto PA, et al. Ann Oncol. 2000 Apr;11(4):487-90. doi: 10.1023/a:1008375418507. Ann Oncol. 2000. PMID: 10847472 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

710 results

Search Page

Filters